About Pharmaids Pharmaceuticals Limited
Data last updated: 14 July 2026
Pharmaids Pharmaceuticals Limited is a public limited company based in Bangalore, Karnataka, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 01 March 1989, the company has been in operation for over 37 years.
Registered with ROC Bangalore under CIN U52520AP1989PLC009679. Listed on BSE: 524572.
Capital: an authorised share capital of ₹101 Cr and a paid-up capital of ₹35.27 Cr. Formerly known as Pharmaids Pharmacuticals Private Limited. It is led by directors including Pattamadai Natarajasarma Vijay and Venu Madhava Kaparthy.
Last AGM: 23 September 2025. Financial statements filed for year ended 31 March 2025. Office: Bangalore, Karnataka.
As per BSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹27.88 Cr, a growth of 43.37% compared to the previous year. The net worth stands at ₹47.6 Cr (down 13.52% YoY). Total assets are valued at ₹87.26 Cr (down 27.19% YoY).
The company has a workforce of approximately 21 employees as per the latest available data.
The company is associated with 1 brand - Pharmaids. As per MCA filings, the company has open charges of ₹10.49 Cr and satisfied charges of ₹1.85 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmaids.com.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered AddressUnit 201 2Nd Floor Brigade Rubix 20/14, Hmt Factory Main Road Peenya Plantation, Bangalore, Karnataka, India – 560013
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Pharmaids Pharmaceuticals Limited
Pharmaids Pharmaceuticals Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L52520KA1989PLC173979, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L52520KA1989PLC173979 | Current |
| U52520AP1989PLC009679 | Previous |
| L52520AP1989PLC009679 | Previous |
| L52520TG1989PLC009679 | Previous |
Associated Brands with Pharmaids Pharmaceuticals Limited
Pharmaids Pharmaceuticals Limited operates one associated brand: Pharmaids. These brands represent Pharmaids Pharmaceuticals Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaids is recognized as a provider of custom research and manufacturing services for pharmaceutical and related industries. | pharmaids.com |
Auditor Details of Pharmaids Pharmaceuticals Limited
Pharmaids Pharmaceuticals Limited is audited by PPKG & Co (ICAI peer reviewed, certificate valid till 2029-01-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| PPKG & Co (ICAI peer reviewed, certificate valid till 2029-01-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors and KMP of Pharmaids Pharmaceuticals Limited
Pharmaids Pharmaceuticals Limited currently reports 7 directors and 2 key managerial personnel. 20 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Pattamadai Natarajasarma Vijay
Also directs:
Jindal Drilling And Industries Limited, Nayara Energy Limited, Rainbow Digital Services Pvt Ltd and 1 more
|
Director | 31 Oct 2022 | 3 Years 9 Months | Current |
|
Balagangadhara Bidanagere Channathimmaiah
Also directs:
Adita Bio Sys Private Limited, Siri Labvivo Diet Private Limited
|
Cfo | 13 Oct 2022 | 3 Years 10 Months | Current |
|
Venu Madhava Kaparthy
Also directs:
Four Seasons Energy Ventures Private Limited
|
Whole-Time Director | 21 May 2022 | 4 Years 3 Months | Current |
| Mini Manikantan | Whole-Time Director | 09 Jul 2022 | 4 Years 1 Months | Current |
|
Nagesh Methuku
Also directs:
Adita Bio Sys Private Limited
|
Director | 29 Nov 2022 | 3 Years 8 Months | Current |
| Yogananda Moolemath | Director | 01 Jan 2026 | 0 Years 7 Months | Current |
Financials of Pharmaids Pharmaceuticals Limited FY 2026 filings available
Pharmaids Pharmaceuticals Limited reported revenue of ₹27.88 Cr (up 43.37% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue from Operations | ₹27.88 Cr | ₹19.45 Cr | ₹15.11 Cr | ₹0 |
| Other Income | ₹28.88 Lakh | ₹10.4 Lakh | ₹87.82 Lakh | ₹0 |
| Total Income | ₹28.17 Cr | ₹19.55 Cr | ₹15.99 Cr | ₹0 |
| Cost of Materials Consumed | ₹14.74 Cr | ₹8.9 Cr | ₹10.27 Cr | ₹0 |
| Purchases of Stock-in-Trade | ₹2.43 Cr | ₹12.79 Cr | ₹4.4 Lakh | ₹0 |
| Changes in Inventories | -₹1.93 Lakh | -₹9.29 Cr | ₹1.16 Cr | ₹88.76 Lakh |
| Employee Benefit Expense | ₹13.38 Cr | ₹13.16 Cr | ₹9.2 Cr | ₹1.13 Cr |
| Finance Costs | ₹3.49 Cr | ₹2.09 Cr | ₹1.57 Cr | ₹46,000 |
| Depreciation & Amortisation | ₹2.03 Cr | ₹2.44 Cr | ₹1.72 Cr | ₹1.68 Lakh |
| Other Expenses | ₹10.89 Cr | ₹6.64 Cr | ₹7.65 Cr | ₹7.87 Cr |
| Total Expenses | ₹46.94 Cr | ₹36.73 Cr | ₹31.61 Cr | ₹9.91 Cr |
| Profit Before Exceptional Items & Tax | -₹18.77 Cr | -₹17.18 Cr | -₹15.62 Cr | -₹9.91 Cr |
| Exceptional Items | ₹2.46 Cr | -₹9.78 Lakh | ₹0 | ₹0 |
| Profit Before Tax | -₹16.3 Cr | -₹17.28 Cr | -₹15.62 Cr | -₹9.91 Cr |
| Total Tax Expense | -₹4.73 Cr | -₹3.77 Cr | -₹3.78 Cr | -₹2.35 Cr |
| Net Profit | -₹11.57 Cr | -₹13.51 Cr | -₹11.84 Cr | -₹7.56 Cr |
| attributable to Owners | -₹11.72 Cr | -₹10.78 Cr | -₹7.97 Cr | - |
| attributable to NCI | ₹14.51 Lakh | -₹2.73 Cr | -₹3.88 Cr | - |
| Other Comprehensive Income | ₹5.08 Lakh | ₹2.05 Lakh | -₹32 Lakh | ₹3.48 Lakh |
| Total Comprehensive Income | -₹11.52 Cr | -₹13.48 Cr | -₹12.16 Cr | -₹7.52 Cr |
| EBITDA (computed) | -₹13.25 Cr | -₹12.65 Cr | -₹12.33 Cr | -₹9.89 Cr |
| Basic EPS | ₹-3.31 | ₹-3.05 | ₹-3.56 | ₹-5.83 |
| Diluted EPS | ₹-3.31 | ₹-3.05 | ₹-3.56 | ₹-5.83 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹87.26 Cr | ₹119.85 Cr | ₹91.34 Cr | ₹24.59 Cr |
| Non-current Assets | ₹76.27 Cr | ₹97.55 Cr | ₹77.81 Cr | ₹7.07 Cr |
| Current Assets | ₹10.99 Cr | ₹22.31 Cr | ₹13.53 Cr | ₹17.51 Cr |
| Property, Plant & Equipment | ₹20.26 Cr | ₹44.65 Cr | ₹31.46 Cr | ₹10.61 Lakh |
| Inventories | ₹41.06 Lakh | ₹12.18 Cr | ₹3.59 Cr | ₹0 |
| Trade Receivables | ₹3.43 Cr | ₹3.13 Cr | ₹2.68 Cr | ₹1.39 Cr |
| Cash & Equivalents | ₹13.35 Lakh | ₹2.14 Cr | ₹4.8 Cr | ₹12.75 Cr |
| Equity (Net Worth) | ₹47.6 Cr | ₹55.04 Cr | ₹70.5 Cr | ₹22.46 Cr |
| Equity Share Capital | ₹35.27 Cr | ₹35.27 Cr | ₹35.27 Cr | ₹21.44 Cr |
| Borrowings (Non-current) | ₹11.84 Cr | ₹30.18 Cr | ₹3.59 Cr | ₹0 |
| Borrowings (Current) | ₹9.07 Cr | ₹5.06 Cr | ₹1.77 Cr | ₹0 |
| Total Debt (computed) | ₹20.91 Cr | ₹35.25 Cr | ₹5.35 Cr | ₹0 |
| Current Liabilities | ₹24.01 Cr | ₹28.71 Cr | ₹11.58 Cr | ₹2.13 Cr |
| Total Liabilities | ₹39.66 Cr | ₹64.81 Cr | ₹20.84 Cr | ₹2.13 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | -₹4.06 Cr | -₹13.99 Cr | -₹10.62 Cr | -₹4.01 Cr |
| Investing Cash Flow | ₹23.34 Cr | -₹12.02 Cr | -₹74.99 Cr | -₹4.94 Cr |
| Financing Cash Flow | -₹19.97 Cr | ₹23.36 Cr | ₹77.66 Cr | ₹21.31 Cr |
| Capital Expenditure | ₹4.47 Cr | ₹12.48 Cr | ₹22.86 Cr | ₹1.67 Cr |
| Free Cash Flow (computed) | -₹8.53 Cr | -₹26.47 Cr | -₹33.48 Cr | -₹5.69 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹68.94 Lakh | -₹2.66 Cr | -₹7.95 Cr | ₹12.35 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹7.18 Cr | ₹5.43 Cr | ₹8.61 Cr | ₹6.66 Cr | ₹4.77 Cr | ₹4.71 Cr | ₹5.24 Cr | ₹4.67 Cr |
| Other Income | ₹9.92 Lakh | ₹7.6 Lakh | ₹22.15 Lakh | ₹4.01 Lakh | ₹7.4 Lakh | ₹73,200 | ₹1.32 Lakh | ₹94,400 |
| Total Income | ₹7.28 Cr | ₹5.51 Cr | ₹8.83 Cr | ₹6.7 Cr | ₹4.84 Cr | ₹4.72 Cr | ₹5.25 Cr | ₹4.68 Cr |
| Cost of Materials Consumed | ₹1.4 Cr | ₹1.07 Cr | ₹9.84 Cr | ₹1.92 Cr | ₹1.73 Cr | ₹2.04 Cr | ₹2.36 Cr | ₹2.76 Cr |
| Purchases of Stock-in-Trade | ₹47.1 Lakh | ₹42.78 Lakh | ₹45.18 Lakh | ₹1.23 Cr | ₹10.36 Cr | ₹99.01 Lakh | ₹1.1 Cr | ₹33.47 Lakh |
| Changes in Inventories | ₹1.88 Cr | ₹85.12 Lakh | -₹2.74 Cr | ₹35.53 Lakh | -₹9.97 Cr | -₹4.28 Lakh | ₹4.66 Lakh | ₹68.22 Lakh |
| Employee Benefit Expense | ₹2.73 Cr | ₹3.28 Cr | ₹3.18 Cr | ₹4.19 Cr | ₹4.05 Cr | ₹3.25 Cr | ₹2.87 Cr | ₹2.99 Cr |
| Finance Costs | ₹64.95 Lakh | ₹71.79 Lakh | ₹1.08 Cr | ₹1.2 Cr | ₹1.01 Cr | ₹48.46 Lakh | ₹33.46 Lakh | ₹26.13 Lakh |
| Depreciation & Amortisation | ₹47.72 Lakh | ₹47.61 Lakh | ₹46.75 Lakh | ₹60.62 Lakh | ₹62.05 Lakh | ₹63.89 Lakh | ₹61.48 Lakh | ₹56.59 Lakh |
| Other Expenses | ₹1.05 Cr | ₹2.3 Cr | ₹3.2 Cr | ₹4.38 Cr | ₹2.5 Cr | ₹1.35 Cr | ₹1.41 Cr | ₹1.31 Cr |
| Total Expenses | ₹8.65 Cr | ₹9.13 Cr | ₹15.47 Cr | ₹13.87 Cr | ₹10.3 Cr | ₹8.72 Cr | ₹8.75 Cr | ₹8.91 Cr |
| Profit Before Exceptional Items & Tax | -₹1.37 Cr | -₹3.62 Cr | -₹6.65 Cr | -₹7.17 Cr | -₹5.46 Cr | -₹4 Cr | -₹3.49 Cr | -₹4.22 Cr |
| Exceptional Items | -₹8.94 Lakh | -₹39.94 Lakh | ₹2.99 Cr | ₹4,000 | ₹5.99 Lakh | -₹1.19 Lakh | -₹6.95 Lakh | -₹7.63 Lakh |
| Profit Before Tax | -₹1.46 Cr | -₹4.02 Cr | -₹3.66 Cr | -₹7.17 Cr | -₹5.4 Cr | -₹4.01 Cr | -₹3.56 Cr | -₹4.3 Cr |
| Total Tax Expense | -₹37.1 Lakh | -₹1.38 Cr | -₹1.13 Cr | -₹1.86 Cr | -₹59.89 Lakh | -₹99.83 Lakh | -₹1 Cr | -₹1.18 Cr |
| Net Profit | -₹1.09 Cr | -₹2.65 Cr | -₹2.53 Cr | -₹5.32 Cr | -₹4.8 Cr | -₹3.01 Cr | -₹2.56 Cr | -₹3.12 Cr |
| attributable to Owners | -₹1.81 Cr | -₹2.48 Cr | -₹2.84 Cr | -₹4.95 Cr | -₹3.94 Cr | -₹1.93 Cr | -₹2.22 Cr | -₹2.68 Cr |
| attributable to NCI | ₹72.41 Lakh | -₹16.72 Lakh | -₹4.79 Lakh | -₹36.39 Lakh | -₹86.43 Lakh | -₹1.08 Cr | -₹34.31 Lakh | -₹44.02 Lakh |
| Other Comprehensive Income | ₹36,000 | ₹1.91 Lakh | ₹1.91 Lakh | ₹90,000 | ₹2.05 Lakh | ₹700 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹1.08 Cr | -₹2.63 Cr | -₹2.51 Cr | -₹5.31 Cr | -₹4.78 Cr | -₹3.01 Cr | -₹2.56 Cr | -₹3.12 Cr |
| EBITDA (computed) | -₹23.99 Lakh | -₹2.43 Cr | -₹5.1 Cr | -₹5.37 Cr | -₹3.83 Cr | -₹2.88 Cr | -₹2.54 Cr | -₹3.4 Cr |
| Basic EPS | ₹-0.51 | ₹-0.70 | ₹-0.70 | ₹-1.41 | ₹-1.11 | ₹-0.55 | ₹-0.73 | ₹-0.76 |
| Diluted EPS | ₹-0.51 | ₹-0.70 | ₹-0.70 | ₹-1.41 | ₹-1.11 | ₹-0.55 | ₹-0.73 | ₹-0.76 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹10.6 Cr | ₹2.34 Cr | ₹2.78 Lakh | ₹0 | ₹3.94 Cr | ₹8.55 Cr | ₹0 | ₹48.1 Lakh |
| Other Income | ₹66.04 Lakh | ₹1.02 Cr | ₹79.5 Lakh | ₹0 | ₹1.51 Lakh | ₹2.63 Lakh | ₹0 | ₹52,000 |
| Total Income | ₹11.26 Cr | ₹3.36 Cr | ₹82.27 Lakh | - | ₹3.95 Cr | ₹8.58 Cr | ₹0 | ₹48.62 Lakh |
| Cost of Materials Consumed | ₹10.91 Cr | ₹3.01 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹39.6 Lakh | ₹11.52 Cr | ₹25.42 Lakh | ₹0 | ₹4.09 Cr | ₹8.53 Cr | ₹0 | ₹35.62 Lakh |
| Changes in Inventories | ₹11.5 Lakh | -₹9.54 Cr | -₹22.93 Lakh | ₹88.76 Lakh | -₹51.85 Lakh | -₹36.91 Lakh | ₹0 | ₹0 |
| Employee Benefit Expense | ₹5.4 Cr | ₹3.42 Cr | ₹1.99 Cr | ₹1.13 Cr | ₹10.44 Lakh | ₹4.43 Lakh | ₹2.28 Lakh | ₹2.83 Lakh |
| Finance Costs | ₹3.3 Cr | ₹2.15 Cr | ₹33.34 Lakh | ₹46,000 | ₹27,000 | ₹0 | ₹8,000 | ₹5,000 |
| Depreciation & Amortisation | ₹21.38 Lakh | ₹19.95 Lakh | ₹17.72 Lakh | - | ₹92,000 | ₹4.48 Lakh | ₹3.88 Lakh | ₹14,000 |
| Other Expenses | ₹7.99 Cr | ₹4.17 Cr | ₹4.39 Cr | ₹7.87 Cr | ₹12.63 Lakh | ₹24.08 Lakh | ₹31.28 Lakh | ₹24.75 Lakh |
| Total Expenses | ₹28.33 Cr | ₹11.95 Cr | ₹6.91 Cr | ₹9.91 Cr | ₹3.81 Cr | ₹8.49 Cr | ₹37.52 Lakh | ₹63.39 Lakh |
| Profit Before Exceptional Items & Tax | -₹17.06 Cr | -₹8.59 Cr | -₹6.09 Cr | - | ₹14.03 Lakh | ₹8.84 Lakh | -₹37.52 Lakh | -₹14.77 Lakh |
| Exceptional Items | ₹3.11 Cr | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹13.95 Cr | -₹8.59 Cr | -₹6.09 Cr | -₹9.91 Cr | ₹14.03 Lakh | ₹8.84 Lakh | -₹37.52 Lakh | -₹14.77 Lakh |
| Total Tax Expense | -₹3.52 Cr | -₹1.31 Cr | -₹1.14 Cr | -₹2.35 Cr | -₹49,000 | -₹48,800 | -₹40.87 Lakh | ₹0 |
| Net Profit | -₹10.44 Cr | -₹7.28 Cr | -₹4.95 Cr | -₹7.56 Cr | ₹14.52 Lakh | ₹9.33 Lakh | ₹3.35 Lakh | -₹18.47 Lakh |
| Other Comprehensive Income | ₹2.89 Lakh | ₹70,000 | ₹0 | - | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹10.41 Cr | -₹7.27 Cr | -₹4.95 Cr | - | ₹14.52 Lakh | ₹9.33 Lakh | ₹3.35 Lakh | -₹18.47 Lakh |
| EBITDA (computed) | -₹13.55 Cr | -₹6.24 Cr | -₹5.58 Cr | - | ₹15.22 Lakh | ₹13.33 Lakh | -₹33.56 Lakh | -₹14.58 Lakh |
| Basic EPS | ₹-2.95 | ₹-2.06 | ₹-2.18 | - | ₹0.14 | ₹0.09 | ₹0.03 | ₹-0.54 |
| Diluted EPS | ₹-2.95 | ₹-2.06 | ₹-2.18 | - | ₹0.14 | ₹0.09 | ₹0.03 | ₹-0.54 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹83.96 Cr | ₹118.69 Cr | ₹85 Cr | ₹24.55 Cr | ₹11.11 Cr | ₹9.12 Cr | ₹8.46 Cr | ₹1.04 Cr |
| Non-current Assets | ₹78.14 Cr | ₹106.01 Cr | ₹80.24 Cr | ₹6.41 Cr | ₹8.44 Cr | ₹8.26 Cr | ₹8.07 Cr | ₹39.93 Lakh |
| Current Assets | ₹5.82 Cr | ₹12.68 Cr | ₹4.76 Cr | ₹18.15 Cr | ₹2.67 Cr | ₹85.73 Lakh | ₹38.73 Lakh | ₹64.29 Lakh |
| Property, Plant & Equipment | ₹7.91 Cr | ₹24.18 Cr | ₹16.55 Cr | - | ₹3.06 Lakh | ₹3.98 Lakh | ₹8.31 Lakh | ₹25,000 |
| Inventories | ₹0 | ₹9.77 Cr | ₹22.93 Lakh | ₹0 | ₹88.76 Lakh | ₹36.91 Lakh | ₹0 | ₹0 |
| Trade Receivables | ₹1.38 Cr | ₹15.62 Lakh | ₹0 | - | ₹1.34 Cr | ₹27.72 Lakh | ₹0 | ₹53.62 Lakh |
| Cash & Equivalents | ₹10.79 Lakh | ₹46.93 Lakh | ₹2.46 Cr | ₹0 | ₹40.75 Lakh | ₹20.03 Lakh | ₹2.18 Lakh | ₹10.67 Lakh |
| Equity (Net Worth) | ₹53.38 Cr | ₹63.79 Cr | ₹71.06 Cr | - | ₹8.67 Cr | ₹8.53 Cr | ₹8.43 Cr | ₹85.73 Lakh |
| Equity Share Capital | ₹35.27 Cr | ₹35.27 Cr | ₹35.27 Cr | - | ₹10.27 Cr | ₹10.27 Cr | ₹10.27 Cr | ₹3.36 Cr |
| Borrowings (Non-current) | ₹14.91 Cr | ₹39.4 Cr | ₹12.5 Cr | - | ₹0 | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹5.54 Cr | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹20.45 Cr | ₹39.4 Cr | ₹12.5 Cr | - | ₹0 | ₹0 | ₹0 | ₹0 |
| Current Liabilities | ₹15.64 Cr | ₹15.23 Cr | ₹1.1 Cr | ₹2.13 Cr | ₹2.44 Cr | ₹58.86 Lakh | ₹2.51 Lakh | ₹18.49 Lakh |
| Total Liabilities | ₹30.58 Cr | ₹54.9 Cr | ₹13.94 Cr | - | ₹2.44 Cr | ₹58.86 Lakh | ₹2.51 Lakh | ₹18.49 Lakh |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹3.53 Cr | -₹7.72 Cr | -₹3.44 Cr | -₹4.02 Cr | -₹25.93 Lakh |
| Investing Cash Flow | ₹24.53 Cr | -₹18.9 Cr | -₹72.51 Cr | -₹4.94 Cr | ₹46.65 Lakh |
| Financing Cash Flow | -₹21.36 Cr | ₹24.64 Cr | ₹65.66 Cr | ₹21.31 Cr | ₹0 |
| Capital Expenditure | ₹2.48 Cr | ₹9.04 Cr | ₹16.37 Cr | - | ₹0 |
| Free Cash Flow (computed) | -₹6.01 Cr | -₹16.76 Cr | -₹19.82 Cr | - | -₹25.93 Lakh |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹36.14 Lakh | -₹1.99 Cr | -₹10.29 Cr | ₹12.35 Cr | ₹20.72 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹2.69 Cr | ₹83.28 Lakh | ₹5.97 Cr | ₹1.12 Cr | ₹13.25 Lakh | ₹1.21 Cr | ₹83.4 Lakh | ₹16.65 Lakh |
| Other Income | ₹6.16 Lakh | ₹6.09 Lakh | ₹19.06 Lakh | ₹34.72 Lakh | ₹1.01 Cr | ₹38,400 | ₹51,100 | ₹31,200 |
| Total Income | ₹2.75 Cr | ₹89.37 Lakh | ₹6.16 Cr | ₹1.46 Cr | ₹1.14 Cr | ₹1.21 Cr | ₹83.91 Lakh | ₹16.96 Lakh |
| Cost of Materials Consumed | ₹71.65 Lakh | ₹33.17 Lakh | ₹9.29 Cr | ₹5.94 Lakh | ₹2.99 Lakh | ₹1,000 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹54.72 Lakh | ₹9.88 Cr | ₹80.35 Lakh | ₹61.5 Lakh | ₹21.7 Lakh |
| Changes in Inventories | ₹1.92 Cr | ₹87.16 Lakh | -₹2.77 Cr | ₹45.71 Lakh | -₹9.77 Cr | ₹25.53 Lakh | ₹4.1 Lakh | -₹6.7 Lakh |
| Employee Benefit Expense | ₹85.24 Lakh | ₹1.55 Cr | ₹1.6 Cr | ₹1.4 Cr | ₹1.09 Cr | ₹86.66 Lakh | ₹71.71 Lakh | ₹73.96 Lakh |
| Finance Costs | ₹59.96 Lakh | ₹57.17 Lakh | ₹1.02 Cr | ₹1.11 Cr | ₹2.05 Cr | ₹6.99 Lakh | ₹1.28 Lakh | ₹1.28 Lakh |
| Depreciation & Amortisation | ₹5.27 Lakh | ₹5.36 Lakh | ₹5.65 Lakh | ₹5.1 Lakh | ₹5.25 Lakh | ₹4.96 Lakh | ₹4.96 Lakh | ₹4.78 Lakh |
| Other Expenses | ₹28.15 Lakh | ₹1.76 Cr | ₹2.43 Cr | ₹3.53 Cr | ₹1.57 Cr | ₹1.01 Cr | ₹59 Lakh | ₹99.4 Lakh |
| Total Expenses | ₹4.42 Cr | ₹5.13 Cr | ₹11.62 Cr | ₹7.15 Cr | ₹4.92 Cr | ₹3.06 Cr | ₹2.03 Cr | ₹1.94 Cr |
| Profit Before Exceptional Items & Tax | -₹1.67 Cr | -₹4.24 Cr | -₹5.46 Cr | -₹5.69 Cr | -₹3.78 Cr | -₹1.85 Cr | -₹1.19 Cr | -₹1.77 Cr |
| Exceptional Items | -₹2.04 Lakh | ₹0 | ₹3.13 Cr | ₹3,000 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹1.69 Cr | -₹4.24 Cr | -₹2.33 Cr | -₹5.69 Cr | -₹3.78 Cr | -₹1.85 Cr | -₹1.19 Cr | -₹1.77 Cr |
| Total Tax Expense | -₹37.87 Lakh | -₹1.13 Cr | -₹68.15 Lakh | -₹1.33 Cr | -₹72.47 Lakh | -₹25.22 Lakh | -₹17.97 Lakh | -₹15.12 Lakh |
| Net Profit | -₹1.31 Cr | -₹3.11 Cr | -₹1.65 Cr | -₹4.36 Cr | -₹3.06 Cr | -₹1.59 Cr | -₹1.01 Cr | -₹1.62 Cr |
| Other Comprehensive Income | ₹2.35 Lakh | ₹18,000 | ₹17,000 | ₹18,000 | ₹70,000 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹1.29 Cr | -₹3.11 Cr | -₹1.65 Cr | -₹4.36 Cr | -₹3.05 Cr | -₹1.59 Cr | -₹1.01 Cr | -₹1.62 Cr |
| EBITDA (computed) | -₹1.02 Cr | -₹3.61 Cr | -₹4.39 Cr | -₹4.53 Cr | -₹1.68 Cr | -₹1.73 Cr | -₹1.12 Cr | -₹1.71 Cr |
| Basic EPS | ₹-0.37 | ₹-0.88 | ₹-0.47 | ₹-1.24 | ₹-0.86 | ₹-0.45 | ₹-0.29 | ₹-0.46 |
| Diluted EPS | ₹-0.37 | ₹-0.88 | ₹-0.47 | ₹-1.24 | ₹-0.86 | ₹-0.45 | ₹-0.29 | ₹-0.46 |
Charges & Borrowings of Pharmaids Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2025 | Axis Bank Limited | ₹6.75 Cr | Open |
| 25 Sep 2025 | State Bank of India | ₹3.74 Cr | Open |
| 15 Sep 2015 | Others | ₹1 Cr | Satisfied |
| 10 Sep 1996 | Central Bank of India | ₹5 Lakh | Satisfied |
| 31 Jul 1995 | Central Bank of India | ₹30 Lakh | Satisfied |
Total charge records: 7 View all charges
Employees and EPFO Compliance at Pharmaids Pharmaceuticals Limited
View historical data on people associated with Pharmaids Pharmaceuticals Limited, including employment history and EPFO contributions.
Employee and EPFO history for Pharmaids Pharmaceuticals Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Pharmaids Pharmaceuticals Limited
GST registrations and filing compliance for Pharmaids Pharmaceuticals Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Pharmaids Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts for Pharmaids Pharmaceuticals Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pharmaids Pharmaceuticals Limited
MSME payment history for Pharmaids Pharmaceuticals Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pharmaids Pharmaceuticals Limited
Corporate group structure for Pharmaids Pharmaceuticals Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pharmaids Pharmaceuticals Limited
MCA filings and documents for Pharmaids Pharmaceuticals Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Pharmaids Pharmaceuticals Limited
Recent News on Pharmaids Pharmaceuticals Limited
Frequently Asked Questions about Pharmaids Pharmaceuticals Limited
Pharmaids Pharmaceuticals Limited is an active public limited company in the pharma sector based in Bangalore, Karnataka, India. It was incorporated on 01 March 1989 (37+ years old) and is registered under CIN L52520KA1989PLC173979. Listed on BSE: 524572. The company has 21 employees.
Pharmaids Pharmaceuticals Limited reported revenue of ₹27.88 Cr for FY 2026 (up 43.37% YoY) based on consolidated BSE filings.
The current directors and KMP of Pharmaids Pharmaceuticals Limited are:
- Pattamadai Natarajasarma Vijay - Director
- Balagangadhara Bidanagere Channathimmaiah - Cfo
- Venu Madhava Kaparthy - Whole-Time Director
- Mini Manikantan - Whole-Time Director
- Nagesh Methuku - Director
- Yogananda Moolemath - Director
- Prasanna Subramanya Bhat - Company Secretary
- Shankarappa Nagaraja Vinaya Babu - Director
- Shreedhara Shetty - Director
The primary industry of Pharmaids Pharmaceuticals Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Pharmaids Pharmaceuticals Limited is listed on BSE with code 524572.
Pharmaids Pharmaceuticals Limited can be reached at the registered office: Unit 201 2Nd Floor Brigade Rubix 2014, Hmt Factory Main Road Peenya Plantation, Bangalore, Karnataka, India – 560013, or through the website pharmaids.com.